BOH
WST icon

Bank of Hawaii’s West Pharmaceutical WST Stock Holding History

Bank of Hawaii’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,495
Closed -$380K – 324
2020
Q1 		$380K Buy
2,495
+670
+37% +$103K 0.03% 220
2019
Q4 		$274K Hold
1,825
– – 0.02% 299
2019
Q3 		$259K Buy
+1,825
New +$251K 0.02% 290

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

Bank of Hawaii's WST Position: Q2 2020 in Review

Bank of Hawaii sold out of West Pharmaceutical (WST) in Q2 2020, closing a stake of 2,495 shares — an estimated $380K sold.

Bank of Hawaii first reported a position in WST in Q3 2019 and held it in 3 quarters. The position peaked at $380K in Q1 2020. 524 funds tracked by Wall St. Rank hold WST as of Q2 2020.

  • Bank of Hawaii reported no remaining West Pharmaceutical position as of Q2 2020 after selling out during the quarter.
  • Bank of Hawaii sold 2,495 West Pharmaceutical shares in Q2 2020, an estimated $380K.
  • Bank of Hawaii first reported a position in West Pharmaceutical in Q3 2019 and held it in 3 quarters.
  • Bank of Hawaii's West Pharmaceutical position peaked at $380K in Q1 2020.
  • 524 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2020.

Based on Bank of Hawaii's 13F filing for Q2 2020, filed 14 Aug 2020.